» Articles » PMID: 33769664

MiR-155 Promotes Colitis-associated Intestinal Fibrosis by Targeting HBP1/Wnt/β-catenin Signalling Pathway

Overview
Journal J Cell Mol Med
Date 2021 Mar 26
PMID 33769664
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Intestinal fibrosis is the most common complication of Crohn's disease (CD) that is one major disorder of inflammatory bowel disease (IBD), but the precise mechanism remains unclear. MiR-155 has been involved in fibrotic diseases. Here, we determined the role of miR-155 in regulating intestinal fibrosis. MiR-155 levels were significantly up-regulated in CD patients with intestinal stricture CD. The overexpression of miR-155 significantly aggravated TNBS-induced CD-associated intestinal fibrosis. Mechanistically, we identified that HBP1, a negative regulator of the Wnt/β-catenin signalling pathway, is a direct target of miR-155. Moreover, in vitro and in vivo experiments suggested that the miR-155/HBP1 axis activates Wnt/β-catenin signalling pathway to induce intestinal fibrosis. Taken together, we demonstrated that miR-155 directly targets HBP1 to induce CD-associated intestinal fibrosis via Wnt/β-catenin signalling pathway.

Citing Articles

Phytochemical Compounds as Promising Therapeutics for Intestinal Fibrosis in Inflammatory Bowel Disease: A Critical Review.

Touny A, Venkataraman B, Ojha S, Pessia M, Subramanian V, Hariharagowdru S Nutrients. 2024; 16(21).

PMID: 39519465 PMC: 11547603. DOI: 10.3390/nu16213633.


The Mechanism of "Treating Different Diseases with the Same Treatment" by Qiangji Jianpi Decoction in Ankylosing Spondylitis Combined with Inflammatory Bowel Disease: A Comprehensive Analysis of Multiple Methods.

Zhang X, Zhou L, Qian X Gastroenterol Res Pract. 2024; 2024:9709260.

PMID: 38808131 PMC: 11132832. DOI: 10.1155/2024/9709260.


RNA methylation in inflammatory bowel disease.

Ozato Y, Hara T, Meng S, Sato H, Tatekawa S, Uemura M Cancer Sci. 2024; 115(3):723-733.

PMID: 38263895 PMC: 10920996. DOI: 10.1111/cas.16048.


Sea Cucumber Peptide Alleviates Ulcerative Colitis Induced by Dextran Sulfate Sodium by Alleviating Gut Microbiota Imbalance and Regulating miR-155/SOCS1 Axis in Mice.

Mao J, Zhao Y, Wang L, Wu T, Jin Y, Meng J Foods. 2023; 12(18).

PMID: 37761144 PMC: 10530247. DOI: 10.3390/foods12183434.


Matrine Protects Intestinal Barrier Function via MicroRNA-155 Through ROCK1-Signaling Pathway.

Yu D, Su D, Liu Z Turk J Gastroenterol. 2023; 34(8):831-838.

PMID: 37326155 PMC: 10544266. DOI: 10.5152/tjg.2023.21884.


References
1.
Beurel E, Grieco S, Jope R . Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther. 2014; 148:114-31. PMC: 4340754. DOI: 10.1016/j.pharmthera.2014.11.016. View

2.
Rupaimoole R, Slack F . MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017; 16(3):203-222. DOI: 10.1038/nrd.2016.246. View

3.
Zargar S, Tomar V, Shyamsundar V, Vijayalakshmi R, Somasundaram K, Karunagaran D . A Feedback Loop between MicroRNA 155 (miR-155), Programmed Cell Death 4, and Activation Protein 1 Modulates the Expression of miR-155 and Tumorigenesis in Tongue Cancer. Mol Cell Biol. 2019; 39(6). PMC: 6399668. DOI: 10.1128/MCB.00410-18. View

4.
Tseng R, Huang W, Lin S, Wu P, Hsu H, Wang Y . HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC. J Cell Mol Med. 2014; 18(9):1752-61. PMC: 4196651. DOI: 10.1111/jcmm.12318. View

5.
Lybrand D, Naiman M, Laumann J, Boardman M, Petshow S, Hansen K . Destruction complex dynamics: Wnt/β-catenin signaling alters Axin-GSK3β interactions . Development. 2019; 146(13). PMC: 6633605. DOI: 10.1242/dev.164145. View